EXECUTIVE SEVERANCE AGREEMENTExecutive Severance Agreement • February 26th, 2026 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 26th, 2026 Company Industry JurisdictionThis EXECUTIVE SEVERANCE AGREEMENT (the “Agreement”) is entered into by and between Akebia Therapeutics, Inc., a Delaware corporation (“Akebia” or the “Company”), and _________________, a resident of _______________ (the “Executive”), and is effective as of ____________ (the “Effective Date”).
AMENDED AND RESTATED EXECUTIVE SEVERANCE AGREEMENTExecutive Severance Agreement • February 26th, 2026 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 26th, 2026 Company Industry JurisdictionThis AMENDED AND RESTATED EXECUTIVE SEVERANCE AGREEMENT (the “Agreement”) is entered into as of the 28th day of January, 2026 (the “Effective Date”), by and between Akebia Therapeutics, Inc., a Delaware corporation (“Akebia” or the “Company”), and John P. Butler, a resident of the Commonwealth of Virginia (the “Executive”).